Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

806 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Assessment of three antibiotic combination regimens against Gram-negative bacteria causing neonatal sepsis in low- and middle-income countries.
Kakaraskoska Boceska B, Vilken T, Xavier BB, Kostyanev T, Lin Q, Lammens C, Ellis S, O'Brien S, da Costa RMA, Cook A, Russell N, Bielicki J, Riddell A, Stohr W, Walker AS, Berezin EN, Roilides E, De Luca M, Romani L, Ballot D, Dramowski A, Wadula J, Lochindarat S, Boonkasidecha S, Namiiro F, Ngoc HTB, Tran MD, Cressey TR, Preedisripipat K, Berkley JA, Musyimi R, Zarras C, Nana T, Whitelaw A, da Silva CB, Jaglal P, Ssengooba W, Saha SK, Islam MS, Mussi-Pinhata MM, Carvalheiro CG, Piddock LJV, Heath PT, Malhotra-Kumar S, Sharland M, Glupczynski Y, Goossens H. Kakaraskoska Boceska B, et al. Among authors: goossens h. Nat Commun. 2024 May 10;15(1):3947. doi: 10.1038/s41467-024-48296-z. Nat Commun. 2024. PMID: 38729951 Free PMC article.
Surveillance for control of antimicrobial resistance.
Tacconelli E, Sifakis F, Harbarth S, Schrijver R, van Mourik M, Voss A, Sharland M, Rajendran NB, Rodríguez-Baño J; EPI-Net COMBACTE-MAGNET Group. Tacconelli E, et al. Lancet Infect Dis. 2018 Mar;18(3):e99-e106. doi: 10.1016/S1473-3099(17)30485-1. Epub 2017 Nov 5. Lancet Infect Dis. 2018. PMID: 29102325 Free article. Review.
Clinical presentation and antimicrobial resistance of invasive Escherichia coli disease in hospitalized older adults: a prospective multinational observational study.
Doua J, Rodríguez-Baño J, Froget R, Puranam P, Go O, Geurtsen J, van Rooij S, Vilken T, Minoru I, Yasumori I, Spiessens B, Tacconelli E, Biehl LM, Thaden JT, Sarnecki M, Goossens H, Poolman J, Bonten M, Ekkelenkamp M; COMBACTE-NET Consortium/EXPECT Study Group. Doua J, et al. Among authors: goossens h. Infection. 2024 Jun;52(3):1073-1085. doi: 10.1007/s15010-023-02163-z. Epub 2024 Jan 25. Infection. 2024. PMID: 38267801 Free PMC article.
One Health surveillance of colistin-resistant Enterobacterales in Belgium and the Netherlands between 2017 and 2019.
De Koster S, Xavier BB, Lammens C, Perales Selva N, van Kleef-van Koeveringe S, Coenen S, Glupczynski Y, Leroux-Roels I, Dhaeze W, Hoebe CJPA, Dewulf J, Stegeman A, Kluytmans-Van den Bergh M, Kluytmans J, Goossens H; i-4-1-Health Study Group. De Koster S, et al. Among authors: goossens h. PLoS One. 2024 Feb 23;19(2):e0298096. doi: 10.1371/journal.pone.0298096. eCollection 2024. PLoS One. 2024. PMID: 38394276 Free PMC article.
A microbiological and genomic perspective of globally collected Escherichia coli from adults hospitalized with invasive E. coli disease.
Arconada Nuin E, Vilken T, Xavier BB, Doua J, Morrow B, Geurtsen J, Go O, Spiessens B, Sarnecki M, Poolman J, Bonten M, Ekkelenkamp M, Lammens C, Goossens H, Glupczynski Y, Van Puyvelde S; COMBACTE-NET Consortium/EXPECT Study Group. Arconada Nuin E, et al. Among authors: goossens h. J Antimicrob Chemother. 2024 Sep 3;79(9):2142-2151. doi: 10.1093/jac/dkae182. J Antimicrob Chemother. 2024. PMID: 39001716 Free PMC article.
Association of Staphylococcus aureus Bacterial Load and Colonization Sites With the Risk of Postoperative S. aureus Infection.
Troeman DPR, Hazard D, van Werkhoven CHW, Timbermont L, Malhotra-Kumar S, Wolkewitz M, Ruzin A, Sifakis F, Harbarth S, Kluytmans JAJW; ASPIRE-SSI Study Group. Troeman DPR, et al. Open Forum Infect Dis. 2024 Jul 23;11(8):ofae414. doi: 10.1093/ofid/ofae414. eCollection 2024 Aug. Open Forum Infect Dis. 2024. PMID: 39113829 Free PMC article.
Aztreonam-avibactam versus meropenem for the treatment of serious infections caused by Gram-negative bacteria (REVISIT): a descriptive, multinational, open-label, phase 3, randomised trial.
Carmeli Y, Cisneros JM, Paul M, Daikos GL, Wang M, Torre-Cisneros J, Singer G, Titov I, Gumenchuk I, Zhao Y, Jiménez-Rodríguez RM, Liang L, Chen G, Pyptiuk O, Aksoy F, Rogers H, Wible M, Arhin FF, Luckey A, Leaney JL, Pypstra R, Chow JW; COMBACTE-CARE consortium REVISIT study group. Carmeli Y, et al. Lancet Infect Dis. 2024 Oct 7:S1473-3099(24)00499-7. doi: 10.1016/S1473-3099(24)00499-7. Online ahead of print. Lancet Infect Dis. 2024. PMID: 39389071
Impact of Pseudomonas aeruginosa carriage on intensive care unit-acquired pneumonia: a European multicentre prospective cohort study.
Recanatini C, van Werkhoven CH, van der Schalk TE, Paling F, Hazard D, Timbermont L, Torrens G, DiGiandomenico A, Esser MT, Wolkewitz M, Sifakis F, Goossens H, Bonten M, Oliver A, Malhotra-Kumar S, Kluytmans J; ASPIRE-ICU Study Team. Recanatini C, et al. Among authors: goossens h. Clin Microbiol Infect. 2024 Nov 10:S1198-743X(24)00533-0. doi: 10.1016/j.cmi.2024.11.007. Online ahead of print. Clin Microbiol Infect. 2024. PMID: 39532190 Free article.
806 results